Latest filing published 25 Jan 2024 for SELLAS Life Sciences Group, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Barbara A. Wood (senior executive) discloses dealings in 3 companies, chiefly IVERIC bio, Inc., OSI Pharmaceuticals Inc and SELLAS Life Sciences Group, Inc. In total, 63 filings cover trades dated from 14 July 2006 to 22 January 2024.
On the market, this insider has only sold: 25 sales, €1.6M in total. Besides market trades, the filings include 19 share grants and 15 option exercises.
The record was last updated on 25 January 2024 with a share grant in SELLAS Life Sciences Group, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 of 14 declarations